Aug 26, 2026
Dr. Carl Rothschild, CEO and Founder, and Eddie Brown, COO of Trifecta Light Technologies, discuss the therapeutic applications of red light and near-infrared therapy by bathing the entire body with these specific light wavelengths. The technology has FDA clearance for fat reduction and healing and clinical research...
Aug 26, 2026
Dr. Carl Rothschild, CEO and Founder, and Eddie Brown, COO of Trifecta Light Technologies, discuss the therapeutic applications of red light and near-infrared therapy by bathing the entire body with these specific light wavelengths. The technology has FDA clearance for fat reduction and healing and clinical research...
Aug 26, 2026
James Sapirstein, CEO of CoCrystal Pharma, is developing a platform of antiviral therapies to treat norovirus, influenza and other viruses. Norovirus, commonly transmitted on cruise ships and in dormitories, currently lacks effective vaccines or treatments. CoCrystal's oral small-molecule approach aims to treat active...
Aug 26, 2026
James Sapirstein, CEO of CoCrystal Pharma, is developing a platform of antiviral therapies to treat norovirus, influenza and other viruses. Norovirus, commonly transmitted on cruise ships and in dormitories, currently lacks effective vaccines or treatments. CoCrystal's oral small-molecule approach aims to treat active...
Aug 25, 2026
Dr. Claire Smith, a regional medical officer at SCP Health and a practicing hospitalist in Missouri, highlights how virtual hospitalists are transforming healthcare by providing 24/7 physician collaboration to support onsite teams, particularly in rural hospitals and during patient surges. Implementing telehospitalists...